Drawing for ZOLARIDE

USPTO serial 78539067

ZOLARIDE

Reviewed by CopyMark Law Group

Reg. 3076118Status 710
Filing date
Status date
Registration date
Apr 4, 2006
Examiner
GAST, PAUL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ZOLARIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wm. Charles Saunders

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP1800 Concord PikeOW2Wilmington, DE 19850

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment and prevention of cancerSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2012C8..CANCELLED SEC. 8 (6-YR)—
Jul 24, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 4, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 21, 2005NPUBNOTICE OF PUBLICATION—
Nov 28, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 18, 2005ALIEASSIGNED TO LIE—
Nov 14, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 7, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 24, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2005MAILPAPER RECEIVED—
Oct 7, 2005CRMLCORRESPONDENCE MAILED—
Oct 7, 2005CNSLSUSPENSION LETTER WRITTEN—
Oct 7, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 26, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2005MAILPAPER RECEIVED—
Aug 2, 2005CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 1, 2005CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 1, 2005DOCKASSIGNED TO EXAMINER—
Jan 10, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance